Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study

CONTEXT: Treatment options for central precocious puberty (CPP) are important for individualization of therapy. OBJECTIVE: We evaluated the efficacy and safety of 6-month 45-mg leuprolide acetate (LA) depot with intramuscular administration. METHODS: LA depot was administered at weeks 0 and 24 to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Karen O, Mauras, Nelly, Nayak, Sunil, Sunil, Bhuvana, Martinez-Placencia, Blanca M, Dragnic, Sanja, Ballina, Mayra, Zhou, Qing, Kansra, Alvina R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274571/
https://www.ncbi.nlm.nih.gov/pubmed/37334213
http://dx.doi.org/10.1210/jendso/bvad071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274571/
https://www.ncbi.nlm.nih.gov/pubmed/37334213
http://dx.doi.org/10.1210/jendso/bvad071

Ejemplares similares